Latest filing published 28 Mar 2024 for Gain Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Matthias Alder: trading record in brief
Matthias Alder discloses dealings in 3 companies, chiefly Sucampo Pharmaceuticals, Inc., Gain Therapeutics, Inc. and Cancervax Corp. Over a trading history stretching from 19 January 2010 to 26 March 2024, the count stands at 30 filings.
Sales make up the whole of the open-market record (7 sales, €2.4M). Besides market trades, the filings include 11 share grants and 12 option exercises.
The latest filing, published on 28 March 2024, reports an option exercise in Gain Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Matthias Alder
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 825 sharesCommon StockSEC:0001493152-24-011836:1
- 637 sharesCommon StockSEC:0001493152-24-011836:2
- 6,085 shares@ US$4.0682.9% of flowCommon StockSEC:0001493152-24-011836:3
- 18,750 sharesCommon StockSEC:0001493152-24-011836:0
- 206 shares@ US$2.461.7% of flowCommon StockSEC:0001209191-23-059558:1
- 637 sharesCommon StockSEC:0001209191-23-059558:0
- 1,820 shares@ US$2.50100.0% of flowCommon StockSEC:0001104659-23-126020:0
- 825 sharesCommon StockSEC:0001209191-23-051502:0
- 2,550 sharesCommon StockSEC:0001209191-23-050379:0
- 3,300 sharesCommon StockSEC:0001209191-23-041027:0
- 673 shares@ US$8.930.2% of flowCommon Stock, Class A (ESPP)SEC:0001171843-17-003999:0
- 641 shares@ US$9.350.2% of flowCommon Stock, Class A (ESPP)SEC:0001171843-17-002917:0
- 33,000 shares0Common stockSEC:0001171843-17-001360:0
- 134 shares@ US$10.460.0% of flowCommon Stock, Class A (ESPP)SEC:0001171843-17-000122:0
- 26,000 shares@ US$8.335.8% of flowCommon Stock, Class ASEC:0001171843-16-013396:0
- 26,000 shares@ US$15.7711.1% of flowCommon Stock, Class ASEC:0001171843-16-013396:1
- 99,025 shares@ US$8.3322.4% of flowCommon Stock, Class ASEC:0001171843-16-013396:2
- 99,025 shares@ US$15.8842.7% of flowCommon Stock, Class ASEC:0001171843-16-013396:3
- 24,975 shares@ US$8.335.6% of flowCommon Stock, Class ASEC:0001171843-16-013396:4
- 24,975 shares@ US$16.7311.3% of flowCommon Stock, Class ASEC:0001171843-16-013396:5
- 639 shares@ US$9.380.2% of flowCommon Stock, Class A (ESPP)SEC:0001171843-16-012572:0
- 752 shares@ US$9.320.2% of flowCommon Stock, Class A (ESPP)SEC:0001171843-16-011123:0
- 645 shares@ US$9.290.2% of flowCommon Stock, Class A (ESPP)SEC:0001171843-16-010706:0
- 477 shares@ US$14.700.2% of flowCommon Stock, Class A (ESPP)SEC:0001171843-16-008379:0
- 523 shares@ US$13.37Common Stock, Class A (ESPP)SEC:0001171843-15-006473:0
25 of 30 declarations
